Shuttle Pharmaceuticals Postpones Special Stockholder Meeting to Sep 9, 2026

What Happened Shuttle Pharmaceuticals Holdings, Inc. filed an 8-K (Sept 2, 2026) announcing that it has postponed its special meeting of stockholders originally scheduled for Thursday, September 3, 2026 at 11:00 a.m. ET. The meeting has been reconvened for Wednesday, September 9, 2026 at 11:00 a.m. ET. Stockholder votes must be received by 11:59 p.m. ET on September 8, 2026 to be counted. Valid proxies submitted before the original meeting remain valid for the reconvened meeting unless changed or revoked.

Key Details

• Original meeting date/time: September 3, 2026 at 11:00 a.m. ET; new date/time: September 9, 2026 at 11:00 a.m. ET.
• Voting deadline for proxy votes: 11:59 p.m. ET on September 8, 2026.
• Reason given: to allow additional time to solicit proxies, give stockholders more time to review and vote on proposals, and to consider an amendment to the terms of certain Milestone Events referenced in the Company’s Sept 1, 2026 Form 8-K.
• Previously submitted proxies remain in effect for the reconvened meeting unless you change or revoke them before votes are taken.

Why It Matters The delay gives stockholders extra time to review the materials and cast (or change) proxy votes on matters that could affect the company, including the noted amendment to Milestone Events. For investors, the postponement may affect the timing of any corporate actions or approvals expected from the special meeting; no financial results or executive changes were reported in this filing. If you intend to vote, note the new deadline (Sept 8) and confirm your proxy status if you want to change your vote.